Providing up to $10 million each year for 4 years, the NSW Biosciences Fund (BioSF) is a competitive technology development and commercialisation grant program that provides individual grants of $200,000–$2 million to companies with innovative technologies, devices and systems in biotechnology and life sciences, biomanufacturing, synthetic biology, and agri-food.
Providing up to $10 million each year for 4 years, the NSW Biosciences Fund (BioSF) is one of three competitive technology development and commercialisation grant programs within the Commercialisation Pathways Program — the Physical Sciences Fund (PSF) and Quantum Computing Commercialisation Fund are the other two funds. The BioSF is modelled on and will complement the PSF.
Round 1 of the BioSF, which is open for preliminary applications till 20 March 2023, provides grants valued between $200,000 and $2 million to companies with innovative technologies, devices and systems in areas including biotechnology and life sciences, biomanufacturing, synthetic biology and agri-food.
BioSF Projects must be for a maximum of 2 years, and must align with one of the three Priority Industries listed in the NSW Industry Development Framework — Agriculture and agrifood; Medical and life sciences; or Clean energy and waste — as well as one of the technology applications identified in the NSW 20-Year R&D Roadmap:
- Genetic Engineering
- Synthetic Biology
- Personalised Medicine
- Cell-based meats
- AgTech
- Sustainable Fuels
- Power to X
- Renewable generation
- Environmental monitoring and management
- Robotics
- AI
- Pharmaceuticals and nutraceuticals
- Circular Economy
- Novel Fertilisers
- Vaccines.
Innovative devices/systems within Technology Readiness Level (TRL) 3–7 are the target of the BioSF, and the idea is to help companies move their product along the TRL scale and commercialise their idea so that they can then attract large-scale private investment.
Examples of what BioSF funding can be spent on include:
- prototyping, manufacturing, and/or scaling of your product;
- conducting market research, testing, and trials;
- regulatory approvals and other relevant certifications;
- salaries and access to external expertise directly related to delivery of the project;
- commercialisation strategies and commercial feasibility studies;
- specialist equipment and/or infrastructure necessary to progress the project;
- fees for IP protection.
If your project is eventually funded by the BioSF and achieves a specified level of economic success, you will be required to repay the grant (terms will be agreed upon as part of contract negotiations).
Applications for the BioSF will be on a yearly basis, till 2026. The preliminary application period for Round 1 of the BioSF closes 20 March 2023. Shortlisting of applicants will then occur followed by invitations for full applications, after which final interviews will be conducted, and funding recipients will likely be announced around October/November 2023. More information (including Guidelines and the online Application form) can be found at the NSW BioSF website.
If you’re an innovative New South Wales business and want the best advice to keep moving onward and upward, contact Fullstack Advisory so you can leverage our expertise and knowledge of all the grants, incentives, rebates, and other opportunities available.
Was this article helpful?
Related Posts
- Business Growth Fund
SMEs with Annual Revenue Above $2 Million Can Now Scale Up by Accessing the $540…
- MVP Grant: Matched Startup Funding to $25,000
Jobs for New South Wales supports hundreds of new NSW-based startups with the MVP Grant.…
- Pharmaceutical R&D: Tax and Funding Incentives
Pharmaceutical R&D is known to be highly intensive and a long-term process, so it is…
- Setting up a Private Ancillary Fund
Private Ancillary funds are charitable trusts that can be beneficial for long-term planning. Learn about…
- The Self-Funded Startup: Make the Right Choices for Success
Some of the most impressive startups are self-funded — but launching your self-funded startup without…
- NSW Government’s MVP Ventures Program
Starting in December 2022, the NSW government is allocating $10 million yearly to its MVP…
- Accelerating Commercialisation – co-fund your venture up to $1 million
Enterprising startups with a prototype available can progress faster with an Accelerating Commericalisation Grant.
- Is Your NSW Business Entitled to the $1500 Rebate?
As part of the COVID recovery program, the NSW government’s Small Business Fees and Charges…
- Export Assistance Grant (NSW)
The Export Assistance Grant provides exporting businesses in NSW with funding to help them access…
- NSW Medical Devices Fund: $8.2 Million Awarded Yearly in Grants of $500k–$5 Million
Since its first round in 2013, more than $70 million has been disbursed from the…
- NSW Medical Devices Fund: $8.2 Million Awarded Yearly in Grants of $500k–$5 Million
Since its first round in 2013, more than $70 million has been disbursed from the…